IXICO (IXI) Competitors GBX 11.66 -0.09 (-0.72%) (As of 12/20/2024 04:19 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades IXI vs. OBI, OPTI, AOR, RLM, NSCI, ONC, SNG, BVX, APTA, and CIZShould you be buying IXICO stock or one of its competitors? The main competitors of IXICO include Ondine Biomedical (OBI), OptiBiotix Health (OPTI), AorTech International (AOR), Realm Therapeutics (RLM), NetScientific (NSCI), Oncimmune (ONC), Synairgen (SNG), BiVictriX Therapeutics (BVX), Aptamer Group (APTA), and Cizzle Biotechnology (CIZ). These companies are all part of the "biotechnology" industry. IXICO vs. Ondine Biomedical OptiBiotix Health AorTech International Realm Therapeutics NetScientific Oncimmune Synairgen BiVictriX Therapeutics Aptamer Group Cizzle Biotechnology Ondine Biomedical (LON:OBI) and IXICO (LON:IXI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, community ranking, earnings, profitability and analyst recommendations. Which has higher valuation & earnings, OBI or IXI? IXICO has higher revenue and earnings than Ondine Biomedical. IXICO is trading at a lower price-to-earnings ratio than Ondine Biomedical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOndine Biomedical£1.63M13.97-£14.27M-£0.03-273.67IXICO£6M0.94-£1.87M-£0.04-291.63 Does the MarketBeat Community favor OBI or IXI? IXICO received 143 more outperform votes than Ondine Biomedical when rated by MarketBeat users. However, 100.00% of users gave Ondine Biomedical an outperform vote while only 71.64% of users gave IXICO an outperform vote. CompanyUnderperformOutperformOndine BiomedicalOutperform Votes1100.00% Underperform VotesNo VotesIXICOOutperform Votes14471.64% Underperform Votes5728.36% Is OBI or IXI more profitable? Ondine Biomedical has a net margin of 0.00% compared to IXICO's net margin of -31.10%. IXICO's return on equity of -16.99% beat Ondine Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Ondine BiomedicalN/A -685.59% -159.71% IXICO -31.10%-16.99%-10.40% Which has more risk and volatility, OBI or IXI? Ondine Biomedical has a beta of 0.1, meaning that its stock price is 90% less volatile than the S&P 500. Comparatively, IXICO has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500. Do insiders and institutionals have more ownership in OBI or IXI? 20.6% of Ondine Biomedical shares are owned by institutional investors. Comparatively, 56.0% of IXICO shares are owned by institutional investors. 36.7% of Ondine Biomedical shares are owned by company insiders. Comparatively, 30.3% of IXICO shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media favor OBI or IXI? In the previous week, Ondine Biomedical had 1 more articles in the media than IXICO. MarketBeat recorded 3 mentions for Ondine Biomedical and 2 mentions for IXICO. IXICO's average media sentiment score of 0.55 beat Ondine Biomedical's score of 0.29 indicating that IXICO is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ondine Biomedical 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IXICO 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryIXICO beats Ondine Biomedical on 8 of the 15 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get IXICO News Delivered to You Automatically Sign up to receive the latest news and ratings for IXI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IXI vs. The Competition Export to ExcelMetricIXICOBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£5.64M£165.68M£5.14B£1.91BDividend Yield1.27%3.64%5.09%5.45%P/E Ratio-291.63115.5190.051,867.09Price / Sales0.9418,531.021,116.25393,302.55Price / Cash2.2512.8743.1028.64Price / Book0.568.594.782.81Net Income-£1.87M-£20.67M£120.31M£155.77M7 Day Performance1.43%-1.05%-1.92%-2.02%1 Month Performance-10.06%174.77%13.65%21.67%1 Year Performance-13.59%134.18%28.34%29.76% IXICO Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IXIIXICON/AGBX 11.67-0.7%N/A-13.6%£5.64M£6M-291.6389OBIOndine BiomedicalN/AGBX 8+5.3%N/A-6.2%£22.18M£1.63M-253.33N/AGap DownOPTIOptiBiotix HealthN/AGBX 22.60+6.6%N/A-26.9%£22.13M£1.26M-753.331High Trading VolumeAORAorTech InternationalN/AN/AN/AN/A£19.99M£539,000.00-33.383RLMRealm TherapeuticsN/AGBX 11.50flatN/AN/A£13.41M£501,919.00-0.66N/ANSCINetScientificN/AGBX 53.50flatN/AN/A£12.81M£1.45M-486.3626ONCOncimmuneN/AGBX 15.85+8.1%N/A-41.3%£11.75M£1.21M-528.3352SNGSynairgenN/AGBX 4.38-0.2%N/A-70.1%£8.82M£79,000.00-144.7334Gap DownBVXBiVictriX TherapeuticsN/AGBX 10+17.6%N/AN/A£8.25MN/A-250.0017Gap UpHigh Trading VolumeAPTAAptamer GroupN/AN/AN/A-69.6%£8.06M£1.03M-4.7837Positive NewsHigh Trading VolumeCIZCizzle BiotechnologyN/AGBX 1.75-2.8%N/A-14.6%£6.94M£25,000.00-171.004 Related Companies and Tools Related Companies OBI Competitors OPTI Competitors AOR Competitors RLM Competitors NSCI Competitors ONC Competitors SNG Competitors BVX Competitors APTA Competitors CIZ Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:IXI) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IXICO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share IXICO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IXI Stock Alerts